scholarly journals 5′-Nucleotidase Plays a Key Role in Uric Acid Metabolism of Bombyx mori

Cells ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 2243
Author(s):  
Linmeng Tang ◽  
Dehong Yang ◽  
Yaohui Wang ◽  
Xu Yang ◽  
Kai Chen ◽  
...  

Uric acid (UA) is the end-product in the human purine metabolism pathway. The UA that accumulates in silkworm tissues is excreted as a nitrogen waste product. Here, we first validated that Bombyx mori has a homolog of the human gene that encodes the 5′-nucleotidase (5′N) involved in purine metabolism. The B. mori gene, Bm5′N, is located upstream of other genes involved in UA metabolism in the silkworm. Disruption of Bm5′N via the CRISPR/Cas9 system resulted in decreased UA levels in the silkworm epidermis and caused a translucent skin phenotype. When Bm5′N mutant silkworms were fed with the uric acid precursor inosine, the UA levels in the epidermis increased significantly. Furthermore, the metabolomic and transcriptomic analyses of Bm5′N mutants indicated that loss of the Bm5′N affected purine metabolism and the ABC transport pathway. Taken together, these results suggest that the UA pathway is conserved between the silkworm and humans and that the Bm5′N gene plays a crucial role in the uric acid metabolism of the silkworm. Thus, the silkworm may be a suitable model for the study of UA metabolism pathways relevant to human disease.

2020 ◽  
Vol 26 ◽  
Author(s):  
Ilkay Erdogan Orhan ◽  
Fatma Sezer Senol Deniz

: Xanthine oxidase (EC 1.17.3.2) (XO) is one of the main enzymatic sources that create reactive oxygen species (ROS) in the living system. It is a dehydrogenase enzyme that performs electron transfer to nicotinamide adenine dinucleotide (NAD+ ), while oxidizing hypoxanthin, which is an intermediate compound in purine catabolism, first to xanthine and then to uric acid. XO turns into an oxidant enzyme that oxidizes thiol groups under certain stress conditions in the tissue. The last metabolic step, in which hypoxanthin turns into uric acid, is catalyzed by XO. Uric acid, considered a waste product, can cause kidney stones and gouty-type arthritis as it is crystallized, when present in high concentrations. Thus, XO inhibitors are one of the drug classes used against gout, a purine metabolism disease that causes urate crystal storage in the joint and its surroundings caused by hyperuricemia. Urate-lowering therapy include XO inhibitors that reduce uric acid production as well as uricosuric drugs that increase urea excretion. Current drugs that obstruct uric acid synthesis through XO inhibition are allopurinol, febuxostat, and uricase. However, since the side effects, safety and tolerability problems of some current gout medications still exist; intensive research is ongoing to look for new, effective, and safer XO inhibitors of natural or synthetic origins for the treatment of the disease. In the present review, we aimed to assess in detail XO inhibitory capacities of pure natural compounds along with the extracts from plants and other natural sources via screening Pubmed, Web of Science (WoS), Scopus, and Google Academic. The data pointed out to the fact that natural products, particularly phenolics such as flavonoids (quercetin, apigenin, and scutellarein), tannins (agrimoniin and ellagitannin), chalcones (melanoxethin), triterpenes (ginsenoside Rd and ursolic acid), stilbenes (resveratrol and piceatannol), alkaloids (berberin and palmatin) have a great potential for new XO inhibitors capable of use against gout disease. In addition, not only plants but other biological sources such as microfungi, macrofungi, lichens, insects (silk worms, ants, etc) seem to be the promising sources of novel XO inhibitors.


2019 ◽  
Vol 15 (1) ◽  
pp. 67-71 ◽  
Author(s):  
Giovambattista Desideri ◽  
Raffaella Bocale ◽  
Anna Maria D’Amore ◽  
Giulia Carnassale ◽  
Stefano Necozione ◽  
...  

1923 ◽  
Vol 55 (3) ◽  
pp. 373-384
Author(s):  
Howard B. Lewis ◽  
Ralph C. Corley
Keyword(s):  

1914 ◽  
Vol 19 (4) ◽  
pp. 473-485
Author(s):  
G.W. Raiziss ◽  
H. Dubin ◽  
A.I. Ringer
Keyword(s):  

2021 ◽  
Author(s):  
Xiaofei Zhou ◽  
Bowei Zhang ◽  
Xiuli Zhao ◽  
Yongxi Lin ◽  
Jin Wang ◽  
...  

Hyperuricemia (HUA) is induced by abnormal purine metabolism and elevated serum uric acid (UA) concentrations, and it is often accompanied by inflammatory responses and intestinal disorders. This study aims to...


1983 ◽  
pp. 155-172
Author(s):  
Edwin Mejías ◽  
Manuel Martínez-Maldonado
Keyword(s):  

1991 ◽  
Vol 67 (11) ◽  
pp. 1271-1281
Author(s):  
Naotoshi SATOH ◽  
Kenjiro KIKUCHI ◽  
Tohru HASEGAWA ◽  
Hiroaki KOMURA ◽  
Shin-ichiro SUZUKI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document